News & Perspective

Dec 11, 2012

Dec 11, 2012

HHS offers some forecasts on medical countermeasures

(CIDRAP News) – A new report from the US Department of Health and Human Services (HHS) offers a few predictions on when certain new countermeasures against biological threats will become available, including a forecast for two novel influenza drugs and possibly a next-generation anthrax vaccine within the next 5 years.

Jun 27, 2012

Jun 27, 2012

HHS updates medical countermeasures strategy

(CIDRAP News) – The US Department of Health and Human Services (HHS) recently updated its strategy for developing and acquiring countermeasures against threats such as bioterror attacks and pandemic flu, a document that spells out the federal game plan for the next 5 years.

May 20, 2011

May 20, 2011

WHA passes pandemic review, tweaks virus-sharing framework

(CIDRAP News) – At the World Health Assembly (WHA) in Geneva today, the full group adopted a review of the World Health Organization's (WHO's) performance during the 2009 H1N1 pandemic, while a committee made some last-minute changes to a framework for sharing flu viruses.

May 16, 2011

May 16, 2011

World Health Assembly opens 64th session in Geneva

(CIDRAP News) – Delegates from 193 countries met today in Geneva at the start of the World Health Assembly (WHA), which will address several infectious disease topics, including a report from an independent pandemic review committee, a virus-sharing agreement, and the fate of the world's remaining smallpox virus stocks.

May 26, 2010

May 26, 2010

Legal expert shares lessons from pandemic vaccine campaign

(CIDRAP News) – Legal issues that came into play during the H1N1 flu pandemic provided a useful look at how laws can help ease the availability of the vaccine, but in some instances can work against immunization efforts, according to a legal expert who has analyzed events that unfolded over the past year.

Jun 05, 2009

Jun 05, 2009

Obama seeks more funds for novel flu fight

(CIDRAP News) – President Barack Obama this week asked Congress for another $2 billion in supplemental funds to fight the novel H1N1 influenza epidemic, on top of $2 billion requested a month ago, and also proposed to tap federal economic stimulus funds for up to another $3.1 billion for the same purpose.

Meanwhile, public health advocates said even more may be needed if a nationwide H1N1 vaccination campaign is launched in the fall.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE A seven-part series on the chances for immunizing the world against pandemic flu

Editor's note: This article was originally published in CIDRAP News as a seven-part series running from October 25 through November 2, 2007. It investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Jun 18, 2007

Jun 18, 2007

FLU CONFERENCE COVERAGE New disease-control rules follow reminders of risks

– TORONTO (CIDRAP News) – Ten years after H5N1 avian influenza first began to raise fears of a potential pandemic, the world has a stronger set of tools to contain that virus and similar threats, but also a fresh awareness of humanity's vulnerability to fast-spreading diseases, experts said yesterday at an international conference on flu.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»